DE2161209A1 - Substituierte Imidazole, ihre pharmakologisch verträglichen Salze, Verfahren zu ihrer Herstellung, und diese Verbindungen enthaltende Arzneipräparate - Google Patents

Substituierte Imidazole, ihre pharmakologisch verträglichen Salze, Verfahren zu ihrer Herstellung, und diese Verbindungen enthaltende Arzneipräparate

Info

Publication number
DE2161209A1
DE2161209A1 DE19712161209 DE2161209A DE2161209A1 DE 2161209 A1 DE2161209 A1 DE 2161209A1 DE 19712161209 DE19712161209 DE 19712161209 DE 2161209 A DE2161209 A DE 2161209A DE 2161209 A1 DE2161209 A1 DE 2161209A1
Authority
DE
Germany
Prior art keywords
group
radical
methyl
methoxy
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19712161209
Other languages
German (de)
English (en)
Inventor
James Peaslake; Ward Neal Walton-on-the Hill; Surrey Heyes (Großbritannien). C07d 55-20
Original Assignee
Beecham Group Ltd., Brentford, Middlesex (Grossbritannien)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Ltd., Brentford, Middlesex (Grossbritannien) filed Critical Beecham Group Ltd., Brentford, Middlesex (Grossbritannien)
Publication of DE2161209A1 publication Critical patent/DE2161209A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/52—Nitrogen atoms not forming part of a nitro radical with hetero atoms directly attached to said nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19712161209 1970-12-09 1971-12-09 Substituierte Imidazole, ihre pharmakologisch verträglichen Salze, Verfahren zu ihrer Herstellung, und diese Verbindungen enthaltende Arzneipräparate Pending DE2161209A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5838570A GB1373346A (en) 1970-12-09 1970-12-09 Biologically active imidazoles

Publications (1)

Publication Number Publication Date
DE2161209A1 true DE2161209A1 (de) 1972-06-22

Family

ID=10481482

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19712161209 Pending DE2161209A1 (de) 1970-12-09 1971-12-09 Substituierte Imidazole, ihre pharmakologisch verträglichen Salze, Verfahren zu ihrer Herstellung, und diese Verbindungen enthaltende Arzneipräparate

Country Status (13)

Country Link
AT (1) AT310740B (hu)
BE (1) BE776422A (hu)
CA (1) CA979428A (hu)
DE (1) DE2161209A1 (hu)
ES (1) ES397573A1 (hu)
FR (1) FR2117939B1 (hu)
GB (1) GB1373346A (hu)
HU (1) HU163484B (hu)
IE (1) IE35817B1 (hu)
IL (1) IL38174A0 (hu)
NL (1) NL7116331A (hu)
SE (1) SE7412430L (hu)
ZA (1) ZA717873B (hu)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3720437A4 (en) * 2017-12-06 2021-11-03 Yale University PRODRUGS ACTIVATED BY REDUCTION IN CYTOSOL

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3720437A4 (en) * 2017-12-06 2021-11-03 Yale University PRODRUGS ACTIVATED BY REDUCTION IN CYTOSOL

Also Published As

Publication number Publication date
FR2117939A1 (hu) 1972-07-28
IL38174A0 (en) 1972-01-27
NL7116331A (hu) 1972-06-13
IE35817B1 (en) 1976-05-26
FR2117939B1 (hu) 1975-06-13
GB1373346A (en) 1974-11-13
ZA717873B (en) 1972-08-30
IE35817L (en) 1972-06-09
BE776422A (fr) 1972-06-08
ES397573A1 (es) 1975-10-01
AU3658871A (en) 1973-06-14
AT310740B (de) 1973-10-10
SE7412430L (hu) 1974-10-02
HU163484B (hu) 1973-09-27
CA979428A (en) 1975-12-09

Similar Documents

Publication Publication Date Title
DE2366070C2 (hu)
DE2618694A1 (de) Azapurinone
DE1795763A1 (de) Verfahren zur herstellung von desacylierten vielkernigen indolverbindungen sowie deren estern
EP0242851A1 (de) N-(2'-Aminophenyl)-benzamid-Derivate, Verfahren zu deren Herstellung und deren Verwendung bei der Bekämpfung neoplastischer Erkrankungen
DE1670536B2 (de) Neue 2-Anilino-5-acylamino-pyrimidlne
CH634310A5 (de) Verfahren zur herstellung neuer pyrimidonderivate.
DE2847792C2 (hu)
DE3240727A1 (de) Ergolinderivate, verfahren zu deren herstellung sowie pharmazeutische zubereitungen, die diese enthalten
DE1445675C3 (de) Pyridylharnstoffe und Verfahren zu ihrer Herstellung
DE2161209A1 (de) Substituierte Imidazole, ihre pharmakologisch verträglichen Salze, Verfahren zu ihrer Herstellung, und diese Verbindungen enthaltende Arzneipräparate
DE2832309C2 (hu)
DE2457309A1 (de) 2-phenylhydrazinothiazolin- beziehungsweise 2-phenylhydrazinothiazininderivate sowie ihre verwendung und verfahren zur herstellung derselben
DE1620747C3 (de) Carbothiamin sowie dessen nichttoxische organische oder anorganische Säureadditionssalze sowie Verfahren zur Herstellung dieser Verbindungen
DE2619110A1 (de) Organische verbindungen, ihre verwendung und herstellung
DE2206890A1 (de) Substituierte Methoxyaminderivate, ihre Verwendung und Verfahren zur Herstellung von substituierten Methoxyaminderivaten
DE2535048B2 (de) H2-ChloräthyI)-l-nltroso-3-glycosylharnstoffe, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung der enteren
EP0160173A1 (de) Benzothiazolderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltendes Arzneimittel
DE1695722C3 (de) i-Acyl-3-lndolylcarbonsäurederivate und Verfahren zu ihrer Herstellung
CH636875A5 (de) 4,5,6,7-tetrahydroimidazo(4,5-c)pyridinderivate und verfahren zu ihrer herstellung.
DE2035161C3 (de) L-Leucyl-L-leucyl-L-valyl-L-tyrosinol und seine Säureadditionssalze mit pharmakologisch unbedenklichen Säuren
DE1695220A1 (de) Verfahren zur Herstellung von Pyrolinverbindungen
DE2423725A1 (de) 5-phenyl-4-oxo-delta hoch 2,alphathiazolidinessigsaeureester
DE1670938C3 (de) Am Amidin-Stickstoff substituierte 2-Methyl-3-amidino-chinoxalin-di-N-oxide -(1.4)
DE3200258A1 (de) Substituierte 1-benzoyl-2-phenylimino-imidazolidine, deren saeureadditionssalze, verfahren zu deren herstellung und diese enthaltende arzneimittel
DE2146450A1 (hu)